par Delattre, Isabelle Karine;Musuamba, Flora T;Jacqmin, Philippe;Taccone, Fabio 
;Laterre, Pierre-Francois;Verbeeck, Roger K.;Jacobs, Frédérique ;Wallemacq, Pierre
Référence Clinical biochemistry, 45, 10-11, page (780-786)
Publication Publié, 2012-07
;Laterre, Pierre-Francois;Verbeeck, Roger K.;Jacobs, Frédérique ;Wallemacq, PierreRéférence Clinical biochemistry, 45, 10-11, page (780-786)
Publication Publié, 2012-07
Article révisé par les pairs
| Résumé : | The study aimed to characterize the pharmacokinetics (PK) of four β-lactams (piperacillin, ceftazidime, cefepime, and meropenem) in patients comedicated with amikacin (AMK), and to confirm the predictive performance of AMK data, obtained from therapeutic drug monitoring (TDM), on these PK, using a population modeling approach. |
